| High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer … DM Abd El‐Rehim, G Ball, SE Pinder, E Rakha, C Paish, JFR Robertson, ... International journal of cancer 116 (3), 340-350, 2005 | 693 | 2005 |
| Effects of β-alanine supplementation on exercise performance: a meta-analysis RM Hobson, B Saunders, G Ball, RC Harris, C Sale Amino acids 43, 25-37, 2012 | 611 | 2012 |
| Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome SE Elsheikh, AR Green, EA Rakha, DG Powe, RA Ahmed, HM Collins, ... Cancer research 69 (9), 3802-3809, 2009 | 577 | 2009 |
| MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer AJ Lowery, N Miller, A Devaney, RE McNeill, PA Davoren, C Lemetre, ... Breast cancer research 11, 1-18, 2009 | 556 | 2009 |
| An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers G Ball, S Mian, F Holding, RO Allibone, J Lowe, S Ali, G Li, S McCardle, ... Bioinformatics 18 (3), 395-404, 2002 | 319 | 2002 |
| Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999 RW Blamey, IO Ellis, SE Pinder, AHS Lee, RD Macmillan, DAL Morgan, ... European journal of cancer 43 (10), 1548-1555, 2007 | 295 | 2007 |
| Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen HO Habashy, DG Powe, CM Staka, EA Rakha, G Ball, AR Green, ... Breast cancer research and treatment 119, 283-293, 2010 | 284 | 2010 |
| An introduction to artificial neural networks in bioinformatics—application to complex microarray and mass spectrometry datasets in cancer studies LJ Lancashire, C Lemetre, GR Ball Briefings in bioinformatics 10 (3), 315-329, 2009 | 245 | 2009 |
| NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting RW McGilvray, RA Eagle, NFS Watson, A Al-Attar, G Ball, I Jafferji, ... Clinical Cancer Research 15 (22), 6993-7002, 2009 | 226 | 2009 |
| Network Inference Analysis Identifies an APRR2-Like Gene Linked to Pigment Accumulation in Tomato and Pepper Fruits Y Pan, G Bradley, K Pyke, G Ball, C Lu, R Fray, A Marshall, S Jayasuta, ... Plant Physiology 161 (3), 1476-1485, 2013 | 215 | 2013 |
| ONCOPOOL–a European database for 16,944 cases of breast cancer RW Blamey, B Hornmark-Stenstam, G Ball, M Blichert-Toft, L Cataliotti, ... European journal of cancer 46 (1), 56-71, 2010 | 177 | 2010 |
| A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences AM Shaaban, GR Ball, RA Brannan, G Cserni, AD Benedetto, J Dent, ... Breast cancer research and treatment 133, 949-958, 2012 | 153 | 2012 |
| Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients S Mian, S Ugurel, E Parkinson, I Schlenzka, I Dryden, L Lancashire, ... Journal of clinical oncology 23 (22), 5088-5093, 2005 | 150 | 2005 |
| Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer EA Rakha, D Soria, AR Green, C Lemetre, DG Powe, CC Nolan, ... British journal of cancer 110 (7), 1688-1697, 2014 | 147 | 2014 |
| Delayed disease progression after allogeneic cell vaccination in hormone-resistant prostate cancer and correlation with immunologic variables A Michael, G Ball, N Quatan, F Wushishi, N Russell, J Whelan, ... Clinical cancer research 11 (12), 4469-4478, 2005 | 146 | 2005 |
| An international cooperative programme indicates the widespread occurrence of ozone injury on crops J Benton, J Fuhrer, BS Gimeno, L Skärby, D Palmer-Brown, G Ball, ... Agriculture, ecosystems & environment 78 (1), 19-30, 2000 | 142 | 2000 |
| Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer TMA Abdel-Fatah, R Russell, N Albarakati, DJ Maloney, D Dorjsuren, ... Molecular oncology 8 (7), 1326-1338, 2014 | 139 | 2014 |
| MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours AR Green, MA Aleskandarany, D Agarwal, S Elsheikh, CC Nolan, ... British journal of cancer 114 (8), 917-928, 2016 | 138 | 2016 |
| A case-controlled study of the oncologic safety of fat grafting KL Gale, EA Rakha, G Ball, VK Tan, SJ McCulley, RD Macmillan Plastic and reconstructive surgery 135 (5), 1263-1275, 2015 | 136 | 2015 |
| Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer AM McDermott, N Miller, D Wall, LM Martyn, G Ball, KJ Sweeney, MJ Kerin PloS one 9 (1), e87032, 2014 | 132 | 2014 |
Jonathan M. GaribaldiUniversity of NottinghamVerified email at cs.nott.ac.uk
